Task: Answer the following question about the molecule with SMILES CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Clinical Phase unknown
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1
CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1
3-(2-chloranyl-5-methylsulfanyl-phenyl)-1-methyl-1-(3-methylsulfanylphenyl)guanidine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.